ArticleCancer science2020

Antitumor activity of cyclin-dependent kinase inhibitor alsterpaullone in Epstein-Barr virus-associated lymphoproliferative disorders.

Takahiro Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.